The CSF3R T618I mutation as a disease-specific marker of atypical CML post allo-SCT von Langabeer, S E, McCarron, S L, Haslam, K, O'Donovan, M T, Conneally, E

Volltext

Aquagenic pruritus and the JAK2 V617F mutation von Langabeer, S. E.

Volltext

The JAK2 V617F mutation in lung cancer: caveat emptor von Langabeer, S E

Volltext

Frequency and spectrum of atypical BCR-ABL1 transcripts in chronic myeloid leukemia von Kearney, L, Crampe, M, Langabeer, S E

Volltext

Targeted next-generation sequencing identifies clinically relevant mutations in patients with chronic neutrophilic leukemia at diagnosis and blast crisis von Langabeer, S. E., Haslam, K., Kelly, J., Quinn, J., Morrell, R., Conneally, E.

Volltext

Lack of National Consensus for the Molecular Investigation of Myeloproliferative Neoplasms von Langabeer, S E

Volltext

Suboptimal molecular response to tyrosine kinase inhibition associated with acquisition of a T240A ABL1 kinase domain mutation in a patient with chronic myeloid leukemia von Langabeer, S E, Haslam, K, Crampe, M, MacDonagh, B, McHugh, J

Volltext

Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia von LANGABEER, S. E, GALE, R. E, HARVEY, R. C, COOK, R. W, MACKINNON, S, LINCH, D. C

Volltext

Anagrelide and the CALR mutation allele burden in essential thrombocythemia von Atkinson, E, Bakri, M, Hayat, A, Langabeer, S E

Volltext

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the... von Kottaridis, Panagiotis D., Gale, Rosemary E., Frew, Marion E., Harrison, Georgina, Langabeer, Stephen E., Belton, Andrea A., Walker, Helen, Wheatley, Keith, Bowen, David T., Burnett, Alan K., Goldstone, Anthony H., Linch, David C.

Volltext

Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials von Langabeer, S. E., Walker, H., Rogers, J. R., Burnett, A. K., Wheatley, K., Swirsky, D., Goldstone, A. H., Linch, D. C.

Volltext

EVI1 expression in acute myeloid leukaemia von Langabeer, S. E., Rogers, J. R., Harrison, G., Wheatley, K., Walker, H., Bain, B. J., Burnett, A. K., Goldstone, A. H., Linch, D. C., Grimwade, D., On Behalf Of The Mrc Adult Leukaemia Working Party

Volltext

Correlation of the BRAF V600E mutation in hairy cell leukaemia with morphology, cytochemistry and immunophenotype von LANGABEER, S. E., O'BRIEN, D., LIPTROT, S., FLYNN, C. M., HAYDEN, P. J., CONNEALLY, E., BROWNE, P. V., VANDENBERGHE, E.

Volltext

Frequency of CBFβ/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials von LANGABEER, S. E., WALKER, H., GALE, R. E., WHEATLEY, K., BURNETT, A. K., GOLDSTONE, A. H., LINCH, D. C.

Volltext

A novel, variant BCR-ABL1 transcript not detected by standard real-time quantitative PCR in a patient with chronic myeloid leukaemia von McCarron, S. L., Haslam, K., Kelly, J., Duggan, C., Langabeer, S. E.

Volltext

Reported cryptic rearrangements of CBFβ-MYH11 in acute myeloid leukaemia are not due to false priming of contaminating DNA von Langabeer, S E, Gale, R E, Walker, H, Linch, D C

Volltext

Screening for CRLF2 overexpression in adult acute lymphoblastic leukemia von Haslam, K., Kelly, J., Morris, T., Connaghan, G., Gilligan, O., Browne, P., Langabeer, S.E.

Volltext

A study to determine whether trisomy 8, deleted 9q and trisomy 22 are markers of cryptic rearrangements of PML/RARα, AML1/ETO and CBFB/MYH11 respectively in acute myeloid leukaemia... von LANGABEER, S. E, GRIMWADE, D, WALKER, H, ROGERS, J. R, BURNETT, A. K, GOLDSTONE, A. H, LINCH, D. C

Volltext

AML with t(8;21) and trisomy 4: possible involvement of c-kit? von Langabeer, S E, Beghini, A, Larizza, L

Volltext

Frequency of CBF beta/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials. The MRC Adult Leukaemia Working Party von Langabeer, S E, Walker, H, Gale, R E, Wheatley, K, Burnett, A K, Goldstone, A H, Linch, D C

Volltext